Patient #07 was managed with salvage intermittent androgen deprivation therapy (ADT) after a biochemical recurrence following prostatectomy in 1999 and had castration-resistant PCa (PSA 3.1 ng/ml) at the time of PSMA PET. The gene discussed is FOLH1; the disease is posterior cortical atrophy.